{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:21:43Z","timestamp":1787862103459,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.clnesp.2022.04.009","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T11:59:56Z","timestamp":1650283196000},"page":"103-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-6498","authenticated-orcid":false,"given":"Christine","family":"March","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazan","family":"Omari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Thormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7140-6775","authenticated-orcid":false,"given":"Maciej","family":"Pech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5871-2586","authenticated-orcid":false,"given":"Andreas","family":"Wienke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9273-3943","authenticated-orcid":false,"given":"Alexey","family":"Surov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2022.04.009_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2022.04.009_bib3","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Liang-Kung","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.clnesp.2022.04.009_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu12030755","article-title":"Reference values for skeletal muscle mass \u2013 current concepts and methodological considerations","volume":"12","author":"Walowski","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2022.04.009_bib5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.clnesp.2022.04.009_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease","volume":"17","author":"Argil\u00e9s","year":"2016","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.clnesp.2022.04.009_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy115","article-title":"Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis","volume":"32","author":"Deng","year":"2019","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.clnesp.2022.04.009_bib8","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00384-018-3128-1","article-title":"Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis","volume":"33","author":"Sun","year":"2018","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.clnesp.2022.04.009_bib9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2015.02.031","article-title":"Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma","volume":"63","author":"Fujiwara","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4143\/crt.2017.232","article-title":"Sarcopenia predicts prognosis in patients with newly diagnosed hepatocellular carcinoma, independent of tumor stage and liver function","volume":"50","author":"Ha","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.clnesp.2022.04.009_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000488779","article-title":"Preoperative visceral adiposity and muscularity predict poor outcomes after hepatectomy for hepatocellular carcinoma","volume":"8","author":"Hamaguchi","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clnesp.2022.04.009_bib12","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.clnesp.2022.04.009_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/hepr.12780","article-title":"Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib","volume":"47","author":"Hiraoka","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clnesp.2022.04.009_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081206","article-title":"Rapid depletions of subcutaneous fat mass and skeletal muscle mass predictworse survival in patients with hepatocellular carcinoma treated with sorafenib","volume":"11","author":"Imai","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.clnesp.2022.04.009_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00535-014-0964-9","article-title":"Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma","volume":"50","author":"Iritani","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib16","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1245\/s10434-014-3686-6","article-title":"Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma","volume":"21","author":"Itoh","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/hepr.12562","article-title":"Sarcopenia is a risk factor for the recurrence of hepatocellular carcinoma after curative treatment","volume":"46","author":"Kamachi","year":"2016","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clnesp.2022.04.009_bib18","article-title":"Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2022.04.009_bib19","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4673-2","article-title":"Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies","volume":"18","author":"Kobayashi","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clnesp.2022.04.009_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/SLA.0000000000002555","article-title":"Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma","volume":"269","author":"Kobayashi","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnesp.2022.04.009_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/s12876-019-1152-4","article-title":"Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study","volume":"19","author":"Mardian","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib22","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.21873\/anticanres.12631","article-title":"No deterioration in clinical outcomes of carbon ion radiotherapy for sarcopenia patients with hepatocellular carcinoma","volume":"38","author":"Shiba","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clnesp.2022.04.009_bib23","first-page":"363","article-title":"Sarcopenia and American society of anesthesiologists physical status in the assessment of outcomes of hepatocellular carcinoma patients undergoing hepatectomy","volume":"70","author":"Takagi","year":"2016","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.clnesp.2022.04.009_bib24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000504604","article-title":"Skeletal muscle mass influences tolerability and prognosis in hepatocellular carcinoma patients treated with Lenvatinib","volume":"9","author":"Uojima","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clnesp.2022.04.009_bib25","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jfma.2020.07.005","article-title":"Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma","volume":"120","author":"Wu","year":"2021","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.clnesp.2022.04.009_bib26","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijsu.2016.04.049","article-title":"Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection","volume":"30","author":"Yabusaki","year":"2016","journal-title":"Int J Surg"},{"key":"10.1016\/j.clnesp.2022.04.009_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu9101054","article-title":"Sarcopenia impairs prognosis of patients with hepatocellular carcinoma: the role of liver functional reserve and tumor-related factors in loss of skeletal muscle volume","volume":"9","author":"Imai","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.clnesp.2022.04.009_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jss.2019.01.007","article-title":"Association between sarcopenia and AFP level in patients undergoing liver transplantation for hepatocellular carcinoma","volume":"238","author":"Acosta","year":"2019","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.clnesp.2022.04.009_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5604\/16652681.1226821","article-title":"Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis","volume":"16","author":"Begini","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.hbpd.2018.07.008","article-title":"Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients","volume":"18","author":"Kroh","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.clnesp.2022.04.009_bib31","article-title":"Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma","volume":"15","author":"Lanza","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2022.04.009_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/jso.23976","article-title":"Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma","volume":"112","author":"Levolger","year":"2015","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib33","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MCG.0b013e318293a825","article-title":"Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma","volume":"47","author":"Meza-Junco","year":"2013","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib34","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/SLA.0000000000000743","article-title":"Sarcopenia impacts on short- and long-term results of hepatectomy for hepatocellular carcinoma","volume":"261","author":"Voron","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.clnesp.2022.04.009_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037563","article-title":"Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma","volume":"7","author":"Mir","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clnesp.2022.04.009_bib36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000484950","article-title":"Association between loss of skeletal muscle mass and mortality and tumor recurrence in hepatocellular carcinoma: a systematic review and meta-analysis","volume":"7","author":"Chang","year":"2018","journal-title":"Liver Cancer"},{"key":"10.1016\/j.clnesp.2022.04.009_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnesp.2022.04.009_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"Quadas-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnesp.2022.04.009_bib39","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Contr Clin Trials"},{"key":"10.1016\/j.clnesp.2022.04.009_bib40","unstructured":"Chapter 10: Analysing data and undertaking meta-analyses | Cochrane Training n.d. https:\/\/training.cochrane.org\/handbook\/archive\/v6\/chapter-10 (accessed March 15, 2021)."},{"key":"10.1016\/j.clnesp.2022.04.009_bib41","doi-asserted-by":"crossref","first-page":"889","DOI":"10.7326\/0003-4819-149-12-200812160-00008","article-title":"Systematic reviews of diagnostic test accuracy","volume":"149","author":"Leeflang","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnesp.2022.04.009_bib42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10120-019-00939-7","article-title":"Correction to: body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis (Gastric Cancer, (2019), 22, 1, (10-22), 10.1007\/s10120-018-0882-2)","volume":"22","author":"Kamarajah","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.clnesp.2022.04.009_bib43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/DCR.0000000000001633","article-title":"Sarcopenia, as assessed by psoas cross-sectional area, is predictive of adverse postoperative outcomes in patients undergoing colorectal cancer surgery","volume":"63","author":"Richards","year":"2020","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clnesp.2022.04.009_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijsu.2018.09.014","article-title":"Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis","volume":"59","author":"Mintziras","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.clnesp.2022.04.009_bib45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13539-010-0014-2","article-title":"An overview of sarcopenia: facts and numbers on prevalence and clinical impact","volume":"1","author":"von Haehling","year":"2010","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2022.04.009_bib46","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00109-008-0373-8","article-title":"Nuclear factor-kappa B signaling in skeletal muscle atrophy","volume":"86","author":"Li","year":"2008","journal-title":"J\u00a0Mol Med"},{"key":"10.1016\/j.clnesp.2022.04.009_bib47","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jcsm.12528","article-title":"Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia","volume":"11","author":"Peixoto da Silva","year":"2020","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2022.04.009_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.clnesp.2022.04.009_bib49","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7314\/APJCP.2015.16.2.613","article-title":"Predictive value of serum insulin-like growth factor-1 in hepatocellular carcinoma","volume":"16","author":"Elmashad","year":"2015","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.clnesp.2022.04.009_bib50","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.clnesp.2022.04.009_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11121861","article-title":"Cachexia and sarcopenia in older adults with cancer: a comprehensive review","volume":"11","author":"Dunne","year":"2019","journal-title":"Cancers"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457722002340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457722002340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:03:00Z","timestamp":1762498980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457722002340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":51,"alternative-id":["S2405457722002340"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2022.04.009","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and role of low skeletal muscle mass (LSMM) in hepatocellular carcinoma. A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2022.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}